As the digital transformation continues to make healthcare more patient-centric, unlocking data will be crucial in informing growing areas of interest such as digital therapeutics (DTx) and the shift towards a more value-based healthcare model. Experts share their predictions for the year ahead.
#rpm
#telehealth
Kaiku Health, the developer of digital health intervention platform in oncology, today announced it will develop digital patient monitoring and management for melanoma patients in collaboration with Novartis, a leading global medicines company. Kaiku Health and Novartis are now aiming to further improve the remote monitoring and support of these patients with the joint development of a therapy-specific module for patients receiving BRAF/MEK combination therapies for melanoma.
#r&d
#rpm
#mobile app
The Netherlands Cancer Institute (NKI), an internationally acclaimed Comprehensive Cancer Center, collaborates with Kaiku Health, an innovator in the field of digital therapeutics for oncology, to develop the next generation of patient-reported outcomes and symptom management. The collaboration is part of a larger clinical trial named NADINA, a phase III trial for neoadjuvant immunotherapy for stage 3 melanoma, where NKI is the principal investigator. NKI uses the Kaiku Health platform in symptom management and patient-reported outcome monitoring of melanoma patients receiving immune checkpoint inhibitor therapies and BRAF/MEK therapies.
#r&d
#rpm
MindMaze Healthcare, the global leader in digital neuro-therapeutics solutions with a mission to accelerate the brain’s ability to recover, learn and adapt, today announced that it has been granted Current Procedural Terminology (CPT®)1 Category III codes published by the American Medical Association (AMA) on November 1, 2021 and effective July 1, 2022.
#rpm
Kaiku Health, the developer of a digital health intervention service in oncology, and MSD Germany, an affiliate of one of the largest pharmaceutical companies in the world, collaborate to develop digital patient monitoring and management for lung cancer patients. In this case, the Kaiku Health Immune Checkpoint Inhibitor module will be used to connect patients with their healthcare providers. In the initial phase of the collaboration, the goal is to pilot the immunotherapy module in cancer centers located in Germany.
#r&d
#rpm
#mobile app
Ypsomed’s insulin pump mylife YpsoPump is now readable via the therapy management software diasend® by Glooko. Therapy data from the mylife App can be sent to diasend® via a secure Cloud-to-Cloud connection. The data transfer to software solutions of third-party suppliers makes the communication between user and physician easier.
#connected device
#insulin pump
#rpm
DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon Valley medical clinic. Auer Integrative will use the DarioEngage™ healthcare provider platform to remotely monitor, engage and manage patients with diabetes and pre-diabetes. The platform allows the clinic to support their all-inclusive patient diabetes management program, in which patients receive health and wellness coaching virtually and via phone. Auer Integrative will adopt Dario's Per Engaged Member, Per Month (PEMPM) business model.
#rpm
#coaching
#virtual care
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis, a telehealth provider specializing in chronic conditions. Eligible Medicare members who have diabetes can receive convenient virtual care for their diabetes, including telehealth delivered by MediOrbis and remote patient monitoring through DarioHealth's AI-powered digital chronic care platform under their existing Medicare benefit.
#product & service
#telehealth
#rpm
Kaiku Health expansion around the world continues as Leben Salud becomes the first user of Kaiku Health in South America. The Argentinian hospital went live with Kaiku Health in November 2021 and currently uses the digital therapeutics platform in radiotherapy.
#institution
#dtx
#rpm
This multicenter (n = 3), retrospective study evaluated all consecutive mRCC patients who participated in the AKO@dom program, which consisted of an app-based and nurse-led weekly patient evaluation at home during the first 3 months of TKI intake. Treatment patterns and modifications were described, and the mean DI (mDI) was calculated at the end of AKO@dom.
#mobile app
#rpm